Independent IR Power Stonegate operates as a leading independent research and investor outreach firm serving over 100 publicly traded clients, with an affiliated investment banking unit. Sales opportunity: position complementary investor relations and outreach services to mid to large-cap clients seeking enhanced market visibility and strategic capital formation.

Healthcare Focus Recent activity highlights Stonegate’s engagement in healthcare and biotech themes, including partnerships and reports on transformative therapies and RNA therapeutics. Sales opportunity: offer specialized healthcare IR commentary, thematic research, and targeted investor outreach programs to biotech and pharma clients seeking to attract U.S. institutional investors.

Growth and Expansion News mentions indicate strategic expansion through thematic reports and large acquisitions within the broader Stonegate ecosystem, signaling scale-up potential in advisory and research services. Sales opportunity: present scalable, multi-tier banking and research solutions for growth-stage and mid-market clients looking to professionalize IR and investor marketing as they scale.

Digital and Data Stack Stonegate’s tech stack includes WordPress, Salesforce, and analytics tools, suggesting established CRM-driven marketing and digital presence. Sales opportunity: propose enhanced digital investor outreach programs, CRM-powered engagement, and analytics dashboards to optimize investor targeting and conversion for public companies.

Financial Scale With revenue in the range of $100M to $250M and a compact team, Stonegate sits between smaller boutique firms and larger banks, offering flexibility and niche expertise. Sales opportunity: tailor cost-effective, high-impact IR and banking services for mid-sized issuers seeking premium capabilities without enterprise-level pricing, including private and public company advisory, and targeted market intelligence.